Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
Hee Tae Yu, Pil‐Sung Yang, Eunsun Jang, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 12
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, et al.
Circulation (2023) Vol. 149, Iss. 1
Open Access | Times Cited: 991
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel, Rónán Collins, Matthias Antz, et al.
EP Europace (2021) Vol. 23, Iss. 10, pp. 1612-1676
Open Access | Times Cited: 843
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 020-047
Open Access | Times Cited: 373
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, et al.
Journal of the American College of Cardiology (2023) Vol. 83, Iss. 1, pp. 109-279
Open Access | Times Cited: 301
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
Dominick J. Angiolillo, Deepak L. Bhatt, Christopher P. Cannon, et al.
Circulation (2021) Vol. 143, Iss. 6, pp. 583-596
Open Access | Times Cited: 233
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim, Udaya S. Tantry, Sidney C. Smith, et al.
Thrombosis and Haemostasis (2020) Vol. 121, Iss. 04, pp. 422-432
Open Access | Times Cited: 217
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Journal of Arrhythmia (2021) Vol. 37, Iss. 6, pp. 1389-1426
Open Access | Times Cited: 69
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 8, Iss. 7, pp. 738-751
Open Access | Times Cited: 47
Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis
Valeria Caso, Joris R. de Groot, Marcelo Sanmartı́n, et al.
Heart (2022) Vol. 109, Iss. 3, pp. 178-185
Open Access | Times Cited: 38
Mortality after major bleeding in Asian atrial fibrillation patients receiving different direct oral anticoagulants: a nationwide, propensity score study
Jiun‐Hao Yu, Pei‐Ru Li, Dong‐Yi Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
Xiaoqin Liu, Ziran Li, Chenyu Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 588-588
Open Access | Times Cited: 12
Oral anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish Multi-center Register of Atrial Fibrillation (POL-AF)
Małgorzata Maciorowska, Beata Uziębło‐Życzkowska, Iwona Gorczyca−Michta, et al.
Kardiologia Polska (2024) Vol. 82, Iss. 1, pp. 37-45
Open Access | Times Cited: 4
Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis
Mariana Q. Pereira, Cláudio David, Ana G. Almeida, et al.
International Journal of Cardiology (2022) Vol. 362, pp. 76-82
Closed Access | Times Cited: 18
Important Risk Factors in Patients with Nonvalvular Atrial Fibrillation Taking Dabigatran Using Integrated Machine Learning Scheme—A Post Hoc Analysis
Yung-Chuan Huang, Yu‐Chen Cheng, Mao-Jhen Jhou, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 756-756
Open Access | Times Cited: 17
Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies
Yi‐Hsin Chan, Chih-Yu Chan, Shao-Wei Chen, et al.
EP Europace (2023) Vol. 25, Iss. 10
Open Access | Times Cited: 10
Clinical characteristics, adherence to anticoagulation therapy and prognosis in patients with atrial fibrillation: a real-life study
Feng Qi, Jiacan Wu, Zhen Xia, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding
Soonil Kwon, So‐Ryoung Lee, Eue‐Keun Choi, et al.
Stroke (2021) Vol. 52, Iss. 2, pp. 511-520
Open Access | Times Cited: 21
Oral Anticoagulant Use in Elderly Japanese Patients With Non-Valvular Atrial Fibrillation ― Subanalysis of the ANAFIE Registry ―
Masaharu Akao, Wataru Shimizu, Hirotsugu Atarashi, et al.
Circulation Reports (2020) Vol. 2, Iss. 10, pp. 552-559
Open Access | Times Cited: 21
Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management
Daniel TT Chong, Felicita Andreotti, Peter Verhamme, et al.
European Cardiology Review (2021) Vol. 16
Open Access | Times Cited: 18
Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
Xiaojuan Wu, Linyan Hu, Jinjin Liu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 18
Residual Stroke Risk in Atrial Fibrillation
Wern Yew Ding
Arrhythmia & Electrophysiology Review (2021) Vol. 10, Iss. 3, pp. 147-153
Open Access | Times Cited: 17
Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation
Tze-Fan Chao, Ngai‐Yin Chan, Yi‐Hsin Chan, et al.
JACC Asia (2023) Vol. 3, Iss. 5, pp. 707-723
Open Access | Times Cited: 7
Acute Ischaemic Stroke in Patients Treated with Direct Oral Anticoagulants: Potential Causes, Clinical Characteristics, and Short-Term Outcomes
Katarzyna Sawczyńska, Ewa Włodarczyk, Aleksandra Pawlicka, et al.
Stroke Research and Treatment (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 2
Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation
Bruria Hirsh Raccah, Yevgeni Erlichman, Arthur Pollak, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2021) Vol. 26, Iss. 6, pp. 601-610
Open Access | Times Cited: 15
Off‐label underdosing of four individual NOACs in patients with nonvalvular atrial fibrillation: A systematic review and meta‐analysis of observational studies
Chuanlan Sang, Jiming Chen, Junyi Sun, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top